1. Home
  2. ZVSA vs NITO Comparison

ZVSA vs NITO Comparison

Compare ZVSA & NITO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVSA
  • NITO
  • Stock Information
  • Founded
  • ZVSA 2014
  • NITO 2009
  • Country
  • ZVSA United States
  • NITO Israel
  • Employees
  • ZVSA N/A
  • NITO N/A
  • Industry
  • ZVSA Biotechnology: Pharmaceutical Preparations
  • NITO
  • Sector
  • ZVSA Health Care
  • NITO
  • Exchange
  • ZVSA Nasdaq
  • NITO NYSE
  • Market Cap
  • ZVSA 3.0M
  • NITO 6.6M
  • IPO Year
  • ZVSA N/A
  • NITO N/A
  • Fundamental
  • Price
  • ZVSA $0.67
  • NITO $0.25
  • Analyst Decision
  • ZVSA
  • NITO
  • Analyst Count
  • ZVSA 0
  • NITO 0
  • Target Price
  • ZVSA N/A
  • NITO N/A
  • AVG Volume (30 Days)
  • ZVSA 1.3M
  • NITO 1.2M
  • Earning Date
  • ZVSA 08-08-2025
  • NITO 08-13-2025
  • Dividend Yield
  • ZVSA N/A
  • NITO N/A
  • EPS Growth
  • ZVSA N/A
  • NITO N/A
  • EPS
  • ZVSA N/A
  • NITO N/A
  • Revenue
  • ZVSA N/A
  • NITO $232,000.00
  • Revenue This Year
  • ZVSA N/A
  • NITO N/A
  • Revenue Next Year
  • ZVSA N/A
  • NITO N/A
  • P/E Ratio
  • ZVSA N/A
  • NITO N/A
  • Revenue Growth
  • ZVSA N/A
  • NITO 24.74
  • 52 Week Low
  • ZVSA $0.47
  • NITO $0.16
  • 52 Week High
  • ZVSA $6.30
  • NITO $3.49
  • Technical
  • Relative Strength Index (RSI)
  • ZVSA 53.47
  • NITO 45.09
  • Support Level
  • ZVSA $0.63
  • NITO $0.22
  • Resistance Level
  • ZVSA $0.71
  • NITO $0.26
  • Average True Range (ATR)
  • ZVSA 0.06
  • NITO 0.02
  • MACD
  • ZVSA 0.00
  • NITO 0.00
  • Stochastic Oscillator
  • ZVSA 66.39
  • NITO 52.94

About ZVSA ZyVersa Therapeutics Inc.

ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are Cholesterol Efflux MediatorTM, VAR 200 (2-hydroxypropyl-beta-cyclodextrin) is an injectable drug in clinical development for the treatment of renal diseases. and IC 100 is a monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of inflammatory conditions.

About NITO N2OFF INC

N2OFF Inc is a pioneering agri-food tech company dedicated to developing sustainable solutions for the plant-based food industry. Operating through two subsidiaries, it delivers integrated solutions for enhanced safety, quality, and sustainability from field to fork. The Company has two reportable segments: Pathogen prevention and prolong shelf life, and the N2O emissions Global warming solutions.

Share on Social Networks: